AstraZeneca PLC (LSE:AZN) - Share price


Stock Report

AstraZeneca PLC AZN

Last Price
GBX10,394.00

Day Change
108.00|1.05%

As of 16/05/2022
15:43:35 BST | GBX
Minimum 15 Minutes Delay.

Last Close10,286.00p
Day Range10,136.00 - 10,410.00
Mkt Cap159.40Bil
52-Wk Range6,499.80 - 11,000.00
Yield %2.04
ISINGB0009895292
Volume1,091,386
P/E1,666.67
P/S3.96
P/CF24.87

Share Price

Total Returns 13/05/2022

 Chg (%)  
More ...
AstraZeneca PLC-2.13 
FTSE 100 TR GBP-1.85
 
Financials
201920202021
More ...
Income Statement
Turnover24,384.0026,617.0037,417.00
Operating Profit1,738.003,916.00-134.00
Net Profit1,227.003,144.00115.00
Reported EPS1.032.440.08
Balance Sheet
Current Assets15,493.0019,544.0025,876.00
Non Current Assets45,814.0047,185.0079,119.00
Total Assets61,377.0066,729.00105,363.00
Current Liabilities18,117.0020,307.0022,594.00
Total Liabilities46,781.0051,091.0066,076.00
Total Equity14,596.0015,638.0039,287.00
Cash Flow
Operating Cash Flow4,087.006,361.007,706.00
Net Change in Cash547.002,311.00-1,446.00

Regulatory News

DateAuthor Headline
28/04/2022James Gard Top FTSE Dividend Paying Stocks
UPDATED for April 2022: it's the first of our monthly dividend updates since the end of the first quarter, which means year-to-date return figures start to look more meaningful
24/11/2020Damien Conover Covid Vaccine Breakthrough: the Morningstar View
Morningstar analyst Damien Conover looks in detail at the latest vaccine developments from AstraZeneca and Pfizer/BioNTech
29/10/2019James Gard Brexit Investment Strategies for Uncertain Times
With a General Election slated for December and Brexit postponed until 2020, investors should consider how their portfolios are positioned for more months of uncertainty 

Company Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Sector

Drug Manufacturers - General

Index

FTSE 100 , FTSE 350 , FTSE All Share , FTSE Eurotop 100 , FTSE Eurotop 300

Next Event 29/07/2022

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)1.97
PEG (E)1.54
ROCE1.22
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date13/08/2125/02/22
Ex-Div12/08/2124/02/22
Paid13/09/2128/03/22
Amnt64.80145.30
Directors
More ...
Non-Executive DirectorMs. Sherilyn D. McCoy
Non-Executive Director, ChairmanMr. Leif Johansson
Non-Executive DirectorMr. Marcus Wallenberg
Non-Executive DirectorMr. Michel Demare
Executive Director, Chief Executive OfficerMr. Pascal Soriot
Non-Executive DirectorMr. Philip A J Broadley
Non-Executive DirectorMs. Deborah DiSanzo
Non-Executive DirectorProfessor Nazneen Rahman
Non-Executive DirectorProfessor Tony Mok
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.